SB 606 New Hampshire 2026 session
relative to insurance coverage for biomarker testing.
Status
- Introduced
- Committee
- Floor vote
- Passed
- Enacted
Passed both chambers — last recorded action May 14, 2026
Refer for Interim Study: MA VV 05/14/2026 HJ 13 P. 9
Passage likelihood
95% Higher than most bills at this stage
This is an estimate, not a guarantee. It is computed from the signals listed below and nothing else. It does not account for leadership priorities, floor scheduling, or negotiations that are not in the public record.
What the estimate is based on
- Historical base rate About 20% of introduced state bills are enacted.
- Current stage Passed both chambers.
- Cosponsors 1 cosponsor.
State-level impact
State-level impact data is not available for this bill. The source text does not contain a per-state funding formula or scored breakdown, so no figures are shown.
Official actions
- Refer for Interim Study: MA VV 05/14/2026 HJ 13 P. 9
- Committee Report: Refer for Interim Study 04/29/2026 (Vote 15-0; CC) HC 19 P. 8
- Subcommittee Work Session: 04/28/2026 10:00 am GP 229
- Executive Session: 04/29/2026 10:00 am GP 229
- Subcommittee Work Session: 04/22/2026 10:00 am GP 229
- Subcommittee Work Session: 04/08/2026 10:00 am GP 229
- Public Hearing: 04/01/2026 11:00 am GP 229
- Introduced (in recess of) 03/12/2026 and referred to Commerce and Consumer Affairs HJ 8 P. 114
- Ought to Pass: MA, VV; OT3rdg; 03/12/2026; SJ 6
- Committee Report: Ought to Pass, 03/12/2026; Vote 7-0; CC; SC 9
- Ought to Pass with Amendment #2026-0689s, MA, VV; Refer to Finance Rule 4-5; 02/19/2026; SJ 4
- Committee Amendment # 2026-0689s, AA, VV; 02/19/2026; SJ 4
- Committee Report: Ought to Pass with Amendment # 2026-0689s, 02/19/2026; Vote 5-0; CC; SC 6
- Hearing: 01/28/2026, Room 100, SH, 09:00 am; SC 3
- Introduced 01/07/2026 and Referred to Health and Human Services; SJ 1